3E8C

Crystal structures of the kinase domain of PKA in complex with ATP-competitive inhibitors

3E8C の概要

• エントリーDOI: 10.2210/pdb3e8c/pdb
• 関連するPDBエントリー: 3E87 3E88 3E8D 3E8E
• 分子名称: cAMP-dependent protein kinase catalytic subunit alpha, cAMP-dependent protein kinase inhibitor peptide, 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-6-{[(2R)-2-amino-3-phenylpropyl]oxy}-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol, ... (4 entities in total)
• 機能のキーワード: pka, akt2, kinase, pki, bovine, inhibitor, atp-binding, camp, lipoprotein, myristate, nucleotide-binding, nucleus, phosphoprotein, serine/threonine-protein kinase, transferase, protein kinase inhibitor
• 由来する生物種: Bos taurus (cow); 詳細
• 細胞内の位置: Cytoplasm : P00517
• タンパク質・核酸の鎖数: 12
• 化学式量合計: 260845.93

構造登録者

Concha, N.O.,Elkins, P.A.,Smallwood, A.,Ward, P. (登録日: 2008-08-19, 公開日: 2008-11-18, 最終更新日: 2024-10-30)

主引用文献

Rouse, M.B.,Seefeld, M.A.,Leber, J.D.,McNulty, K.C.,Sun, L.,Miller, W.H.,Zhang, S.,Minthorn, E.A.,Concha, N.O.,Choudhry, A.E.,Schaber, M.D.,Heerding, D.A.
Aminofurazans as potent inhibitors of AKT kinase
Bioorg.Med.Chem.Lett., 19:1508-1511, 2009

PubMed Abstract: AKT inhibitors containing an imidazopyridine aminofurazan scaffold have been optimized. We have previously disclosed identification of the AKT inhibitor GSK690693, which has been evaluated in clinical trials in cancer patients. Herein we describe recent efforts focusing on investigating a distinct region of this scaffold that have afforded compounds (30 and 32) with comparable activity profiles to that of GSK690693.

PubMed: 19179070
DOI: 10.1016/j.bmcl.2009.01.002

実験手法

X-RAY DIFFRACTION (2.2 Å)